223 related articles for article (PubMed ID: 34508995)
1. Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma.
Alonso-Álvarez S; Manni M; Montoto S; Sarkozy C; Morschhauser F; Wondergem MJ; Guarini A; Magnano L; Alcoceba M; Chamuleau M; Galimberti S; Gomes da Silva M; Holte H; Zucca E; Lockmer S; Aurer I; Marcheselli L; Stepanishyna Y; Caballero Barrigón MD; Salles G; Federico M
Eur J Cancer; 2021 Nov; 157():132-139. PubMed ID: 34508995
[TBL] [Abstract][Full Text] [Related]
2. Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group.
Alonso-Álvarez S; Magnano L; Alcoceba M; Andrade-Campos M; Espinosa-Lara N; Rodríguez G; Mercadal S; Carro I; Sancho JM; Moreno M; Salar A; García-Pallarols F; Arranz R; Cannata J; Terol MJ; Teruel AI; Rodríguez A; Jiménez-Ubieto A; González de Villambrosia S; Bello JL; López L; Monsalvo S; Novelli S; de Cabo E; Infante MS; Pardal E; García-Álvarez M; Delgado J; González M; Martín A; López-Guillermo A; Caballero MD
Br J Haematol; 2017 Sep; 178(5):699-708. PubMed ID: 28782811
[TBL] [Abstract][Full Text] [Related]
3. The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database.
Janikova A; Bortlicek Z; Campr V; Kopalova N; Benesova K; Hamouzova M; Belada D; Prochazka V; Pytlik R; Vokurka S; Pirnos J; Duras J; Mocikova H; Mayer J; Trneny M
Ann Hematol; 2018 Apr; 97(4):669-678. PubMed ID: 29318369
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.
Sarkozy C; Trneny M; Xerri L; Wickham N; Feugier P; Leppa S; Brice P; Soubeyran P; Gomes Da Silva M; Mounier C; Offner F; Dupuis J; Caballero D; Canioni D; Paula M; Delarue R; Zachee P; Seymour J; Salles G; Tilly H
J Clin Oncol; 2016 Aug; 34(22):2575-82. PubMed ID: 27298402
[TBL] [Abstract][Full Text] [Related]
5. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A
Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era.
Sesques P; Bourcier J; Golfier C; Lebras L; Nicolas-Virelizier E; Hacini M; Perrin MC; Voillat L; Bachy E; Traverse-Glehen A; Moreau A; Martin L; Ramla S; Casasnovas O; Le Gouill S; Salles G; Ghesquières H
Hematol Oncol; 2020 Apr; 38(2):137-145. PubMed ID: 31953963
[TBL] [Abstract][Full Text] [Related]
7. Non-diffuse large B-cell lymphoma transformation from follicular lymphoma: a single-institution study of 19 cases.
Maeshima AM; Taniguchi H; Ida H; Hosoba R; Fujino T; Saito Y; Yuda S; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Hum Pathol; 2020 Aug; 102():33-43. PubMed ID: 32540222
[TBL] [Abstract][Full Text] [Related]
8. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis.
Federico M; Caballero Barrigón MD; Marcheselli L; Tarantino V; Manni M; Sarkozy C; Alonso-Álvarez S; Wondergem M; Cartron G; Lopez-Guillermo A; Issa D; Morschhauser F; Alcoceba M; Kimby E; Rusconi C; Chamuleau M; Holte H; Lockmer S; Montoto S; Gomes da Silva M; Aurer I; Zucca E; Paszkiewicz-Kozik E; Minoia C; Skrypets T; Blaker YN; Salles G; Coiffier B;
Lancet Haematol; 2018 Aug; 5(8):e359-e367. PubMed ID: 30078408
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival after histologic transformation of low-grade follicular lymphoma.
Yuen AR; Kamel OW; Halpern J; Horning SJ
J Clin Oncol; 1995 Jul; 13(7):1726-33. PubMed ID: 7602362
[TBL] [Abstract][Full Text] [Related]
10. Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study.
Morschhauser F; Le Gouill S; Feugier P; Bailly S; Nicolas-Virelizier E; Bijou F; Salles GA; Tilly H; Fruchart C; Van Eygen K; Snauwaert S; Bonnet C; Haioun C; Thieblemont C; Bouabdallah R; Wu KL; Canioni D; Meignin V; Cartron G; Houot R
Lancet Haematol; 2019 Aug; 6(8):e429-e437. PubMed ID: 31296423
[TBL] [Abstract][Full Text] [Related]
11. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
Montoto S; Davies AJ; Matthews J; Calaminici M; Norton AJ; Amess J; Vinnicombe S; Waters R; Rohatiner AZ; Lister TA
J Clin Oncol; 2007 Jun; 25(17):2426-33. PubMed ID: 17485708
[TBL] [Abstract][Full Text] [Related]
12. Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group.
Méndez M; Torrente M; Sánchez-Beato M; González-Rincón J; Royuela A; Gómez-Codina J; de la Cruz-Merino L; Rueda A; Llanos M; Quero C; Rodríguez-Abreu D; Gumá J; Monsalvo S; Sabin P; Provencio M
Hematol Oncol; 2019 Apr; 37(2):143-150. PubMed ID: 30840776
[TBL] [Abstract][Full Text] [Related]
13. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
14. Transformation of indolent B-cell lymphomas.
Montoto S; Fitzgibbon J
J Clin Oncol; 2011 May; 29(14):1827-34. PubMed ID: 21483014
[TBL] [Abstract][Full Text] [Related]
15. Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure.
Jiménez-Ubieto A; Grande C; Caballero D; Yáñez L; Novelli S; Hernández-Garcia MT; Manzanares M; Arranz R; Ferreiro JJ; Bobillo S; Mercadal S; Galeo A; López Jiménez J; Moraleda JM; Vallejo C; Albo C; Pérez E; Marrero C; Magnano L; Palomera L; Jarque I; Martínez-Sánchez P; Martín A; Coria E; López-Guillermo A; Salar A; Lahuerta JJ
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1631-1640. PubMed ID: 28533060
[TBL] [Abstract][Full Text] [Related]
16. Transformed follicular lymphoma.
Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
[TBL] [Abstract][Full Text] [Related]
17. Transformed follicular lymphoma (tFL): consolidation therapy may improve survival.
Elhassadi E; Flavin R; Browne P; Conneally E; Hayden P; Quinn F; Higgins E; Vandenberghe E
Ir J Med Sci; 2017 Aug; 186(3):589-595. PubMed ID: 28321641
[TBL] [Abstract][Full Text] [Related]
18. [Follicular lymphoma: first - line selection criteria of treatment].
Nesterova ES; Kravchenko SK; Kovrigina AM; Gemdzhian EG; Plastinina LV; Babaeva FE; Obukhova TN; Magomedova AU; Gaponova TV; Kremenetskaya AM; Vorobyev AI
Ter Arkh; 2019 Aug; 91(8):75-83. PubMed ID: 32598757
[TBL] [Abstract][Full Text] [Related]
19. Transformation Scoring System (TSS): A new assessment index for clinical transformation of follicular lymphoma.
Shichijo T; Maruyama D; Yamauchi N; Maeshima AM; Sugano M; Yuda S; Tajima K; Kurihara H; Shimada K; Suzuki T; Toyoda K; Makita S; Fukuhara S; Munakata W; Suzuki T; Kobayashi Y; Taniguchi H; Minami Y; Izutsu K; Tobinai K
Cancer Med; 2020 Dec; 9(23):8864-8874. PubMed ID: 33022120
[TBL] [Abstract][Full Text] [Related]
20. Treatment of patients with transformed lymphoma.
Montoto S
Hematology Am Soc Hematol Educ Program; 2015; 2015():625-30. PubMed ID: 26637780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
